Point6 Bio is a computational biology company, focused on capturing multi-omics molecular insights from the proteome, including from the subject’s gut microbiome, to identify biomarker signatures, which will eventually affect treatment decisions and new drug targets identification in Autism.

By harnessing computational and systems biology, the company captures multi-omics molecular insights, aimed at driving a paradigm shift for families and transforming ASD care.